Periostina Câncer Pâncreas: USP Descobre Invasão Nervosa
Estudo da USP desvenda como a periostina impulsiona a invasão perineural no câncer de pâncreas, abrindo portas para novos tratamentos no Brasil.
No reviews yet. Be the first to rate Helder!
Helder Nakaya is an associate professor in the Department of Clinical Analyses and Toxicology at the School of Pharmaceutical Sciences of the Universidade de São Paulo. He holds a PhD in Molecular Biology and has extensive training in bioinformatics. Dr. Nakaya is an expert in systems vaccinology, an interdisciplinary field that combines systems-wide measurements, networks, and predictive modeling in the context of vaccines and infectious diseases. He has developed systems biology approaches to understand and predict the mechanisms of vaccine-induced immunity for the yellow fever vaccine, seasonal influenza vaccines, meningococcal vaccines, and tularemia vaccines. His laboratory focuses on investigating the basis of infectious diseases using computational systems biology. Dr. Nakaya also serves as a senior researcher at Hospital Israelita Albert Einstein and as an adjunct professor at Emory University School of Medicine in the Department of Pathology.
Estudo da USP desvenda como a periostina impulsiona a invasão perineural no câncer de pâncreas, abrindo portas para novos tratamentos no Brasil.